Stocks/APGE

APGE three-lens brief

Evidence-based stock research on APGE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$35.39$135.07$135.09

Performance

1W
0.0%
1M
+0.3%
3M
6M
YTD
1Y
3Y
5Y
APGE · Nightly brief
Concern

50-day MA above 200-day MA (golden-cross regime); price above both. · Trading at 100% of its 52-week range — near the top of the band.

  • Trading at 100% of its 52-week range — near the top of the band.
  • 50-day MA above 200-day MA (golden-cross regime); price above both.
  • RSI at 80 — technically overbought.
  • Outperforming SPY by 55.2pp over 30 days.
  • Currently unprofitable on a trailing basis — no P/E multiple available.

APGE closed at $135.07 (0.00%) as of 2026-09-11. Market cap: $10.22B. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 55.2pp over 30 days.. Concerns: trading at 100% of its 52-week range — near the top of the band.; rSI at 80 — technically overbought.. Last quarter: net income -$85.85M, free cash flow -$145.62M.

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on APGE, not one.

A single reasoning model has blind spots it doesn’t know about. We examine APGEacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/APGE"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath APGE brief"></iframe>